Ensysce Biosciences, Inc. Gains 37.17%
Tue, Aug 04, 2026 at 07:35 PM
Ensysce Biosciences, Inc. (ENSC:NASDAQ) rocketted at $0.38, a gain of 37.2%. On Tue, Aug 04, 2026, ENSC:NASDAQ touched a New 2-Week High of $0.38. The stock appeared on our News Catalysts scanner on Tue, Jul 14, 2026 at 09:27 AM in the 'PRIVATE PLACEMENT' category. From Tue, Jul 21, 2026, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Aug 04, 2026 at $0.48 with a volume of 179M+.
About Ensysce Biosciences, Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Autonomix Medical, Inc. (AMIX:NASDAQ), 434.25%
- Adagio Medical Holdings, Inc. (ADGM:NASDAQ), 73.91%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 60.08%
- Direxion Daily PLTR Bull 2X Shares (PLTU:NASDAQ), 57.87%
- Elong Power Holding Limited (ELPW:NASDAQ), 51.95%
- Ibotta, Inc. (IBTA:NYSE), 51.91%
- GlucoTrack, Inc. (GCTK:NASDAQ), 44.28%
- Exagen Inc. (XGN:NASDAQ), 37.82%
- Ensysce Biosciences, Inc. (ENSC:NASDAQ), 37.17%
- Telesat Corporation (TSAT:NASDAQ), 36.26%